AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimihop M Forte 1mg/1000mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Anax Lifescience

Salt Composition

Glimepiride (1mg) + Metformin (1000mg)

Overview Glimihop M Forte 1mg/1000mg Tablet ER

Forcoglime Forte 1mg/1000mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Forcoglime Forte with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor; lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to evaluate blood cell counts and liver function.

Uses of Glimihop M Forte 1mg/1000mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimihop M Forte 1mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Glimihop M Forte 1mg/1000mg Extended-Release tablet whole; do not crush, chew, or break it. Administer this medicine with food.

Common Side effects of Glimihop M Forte 1mg/1000mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimihop M Forte 1mg/1000mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimihop M Forte 1mg/1000mg Extended-Release tablet whole; do not crush, chew, or divide it. This medicine should be administered with food.

How Glimihop M Forte 1mg/1000mg Tablet ER works:

Glimihop M Forte 1mg/1000mg Extended-Release tablets contain glimepiride and metformin, two medications that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Glimihop M Forte 1mg/1000mg ER tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimihop M Forte 1mg/1000mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimihop M Forte tablets (1mg/1000mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimihop M Forte 1mg/1000mg Extended-Release tablets. Dosage modification may be necessary; physician consultation is recommended. This medication is contraindicated in patients with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimihop M Forte 1mg/1000mg Extended-Release tablets cautiously. Dosage modification may be necessary for these patients. Medical advice is recommended. In those with mild to moderate hepatic dysfunction, initiation should be at a low dose; however, the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glimihop M Forte 1mg/1000mg Tablet ER :

Should you forget to take your Glimihop M Forte 1mg/1000mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimihop M Forte 1mg/1000mg Tablet ER

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimihop M Forte 1mg/1000mg Tablet ER

Store the medication in its original, tightly sealed container or packaging. Follow the storage instructions provided on the label or packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Indeed, Glimihop M Forte 1mg/1000mg Extended-Release tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially dangerous adverse reaction is particularly concerning for individuals with pre-existing kidney impairment, the elderly, or those who consume significant quantities of alcohol. Symptoms such as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia warrant immediate cessation of Glimihop M Forte 1mg/1000mg Extended-Release tablet use and prompt medical attention.
Glimihop M Forte 1mg/1000mg Extended-Release tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when combined with a healthy diet and regular physical activity. Glimepiride's action reduces blood glucose by stimulating insulin secretion from the pancreas, while metformin decreases liver glucose production and enhances insulin responsiveness. This dual-drug therapy is unsuitable for individuals with type 1 diabetes.
Glimihop M Forte 1mg/1000mg Extended-Release tablets may cause common adverse events including low blood glucose, taste disturbances, nausea, abdominal discomfort, diarrhea, and cephalalgia. Serious, though infrequent, side effects such as lactic acidosis are also possible. Prolonged administration may result in vitamin B12 deficiency.
Prolonged Glimihop M Forte 1mg/1000mg ER tablet use can indeed lead to Vitamin B12 deficiency. This medication disrupts Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. Preventive measures, according to some studies, include annual supplemental Vitamin B12 intake.
Indeed, Glimihop M Forte 1mg/1000mg Extended-Release tablets can induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremors. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. A readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, should always be carried.
Consuming alcohol concurrently with Glimihop M Forte 1mg/1000mg Extended-Release tablets is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glimihop M Forte 1mg/1000...
46
MRP 56
17% off